| Marilyn R Warren, RN, CNS, RXS | |
|
28374 County Road 317, Buena Vista, CO 81211-9158 | |
| (719) 538-6502 | |
| (719) 539-3988 |
| Full Name | Marilyn R Warren |
|---|---|
| Gender | Female |
| Speciality | Certified Clinical Nurse Specialist (cns) |
| Experience | 22 Years |
| Location | 28374 County Road 317, Buena Vista, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477569473 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Diversus Health Inc | 7719879204 | 36 |
News Archive
Global Health Partner has inaugurated its own clinic for the treatment of obesity and metabolic disorders in Prague and the first obesity operations have been performed. The Czech Republic has a well insured population where patient flows are directed to clinics with strong medical results. "The Czech Republic is one of the markets that we have identified as interesting.
A venom component from the Taipan, the world's deadliest snake, is being developed by Brisbane biotechnology company ElaCor, as a new drug to treat heart failure.
Delcath Systems, Inc. a development stage, specialty pharmaceutical and medical device company focused on oncology will host a conference call to discuss recent corporate developments on Tuesday, June 15, 2010 at 4:30 p.m., Eastern. Eamonn P. Hobbs, the Company's President and CEO, David McDonald, CFO, and Krishna Kandarpa, MD, Chief Medical Officer, will be on hand during the call and webcast.
Genzyme, a Sanofi company announced today that key data from the TOWER trial were presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).
› Verified 3 days ago
| Entity Name | Diversus Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043260243 PECOS PAC ID: 7719879204 Enrollment ID: O20040329000837 |
News Archive
Global Health Partner has inaugurated its own clinic for the treatment of obesity and metabolic disorders in Prague and the first obesity operations have been performed. The Czech Republic has a well insured population where patient flows are directed to clinics with strong medical results. "The Czech Republic is one of the markets that we have identified as interesting.
A venom component from the Taipan, the world's deadliest snake, is being developed by Brisbane biotechnology company ElaCor, as a new drug to treat heart failure.
Delcath Systems, Inc. a development stage, specialty pharmaceutical and medical device company focused on oncology will host a conference call to discuss recent corporate developments on Tuesday, June 15, 2010 at 4:30 p.m., Eastern. Eamonn P. Hobbs, the Company's President and CEO, David McDonald, CFO, and Krishna Kandarpa, MD, Chief Medical Officer, will be on hand during the call and webcast.
Genzyme, a Sanofi company announced today that key data from the TOWER trial were presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marilyn R Warren, RN, CNS, RXS 28374 County Road 317, Buena Vista, CO 81211-9158 Ph: (719) 539-6502 | Marilyn R Warren, RN, CNS, RXS 28374 County Road 317, Buena Vista, CO 81211-9158 Ph: (719) 538-6502 |
News Archive
Global Health Partner has inaugurated its own clinic for the treatment of obesity and metabolic disorders in Prague and the first obesity operations have been performed. The Czech Republic has a well insured population where patient flows are directed to clinics with strong medical results. "The Czech Republic is one of the markets that we have identified as interesting.
A venom component from the Taipan, the world's deadliest snake, is being developed by Brisbane biotechnology company ElaCor, as a new drug to treat heart failure.
Delcath Systems, Inc. a development stage, specialty pharmaceutical and medical device company focused on oncology will host a conference call to discuss recent corporate developments on Tuesday, June 15, 2010 at 4:30 p.m., Eastern. Eamonn P. Hobbs, the Company's President and CEO, David McDonald, CFO, and Krishna Kandarpa, MD, Chief Medical Officer, will be on hand during the call and webcast.
Genzyme, a Sanofi company announced today that key data from the TOWER trial were presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).
› Verified 3 days ago